YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for ...
Physicians identified key improvements for adrenaline auto-injectors, including longer shelf life and easier use, improving anaphylaxis care. Learn more.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results